Inclusion criteria required patients aged 1875 years with established UC for at least 3 months, inadequate response or intolerance to conventional treatments, MES 2, total MS 5-10, and stable concurrent medications, while excluding those with fulminant colitis, recent use of various immunosuppressive agents, active infections, or significant comorbidities
Clinics have the necessary equipment and trained staff to handle any immediate side effects or complications that may arise during your treatment
Tirzepatide for Weight Loss (JAMA Internal Medicine, 2024) Meta-analysis: Comparative Efficacy of Tirzepatide vs
lower endoscopy (HR = 0.56
People with low B12 levels often report irritability, poor concentration, or low mood, all of which can make weight management harder
These findings contributed to current FDA-approved eligibility criteria